[1]
|
Torre, L.A., Bray, F., Siegel, R.L., et al. (2015) Global Cancer Statistics, 2012. Ca A Cancer Journal for Clinicians, 65, 87-108. https://doi.org/10.3322/caac.21262
|
[2]
|
Wang, J.Y., Liu, G.Z., Wilmott, J.S., et al. (2017) Skp2-Mediated Stabilization of MTH1 Promotes Survival of Melanoma Cells upon Oxidative Stress. Cancer Research, 77, 6226. https://doi.org/10.1158/0008-5472.CAN-17-1965
|
[3]
|
Gad, H., Koolmeister, T., Jemth, A.S., et al. (2014) MTH1 Inhibition Eradicates Cancer by Preventing Sanitation of the dNTP Pool. Nature, 508, 215. https://doi.org/10.1038/nature13181
|
[4]
|
Torre, L.A., Siegel, R.L., Ward, E.M., et al. (2016) Global Cancer Inci-dence and Mortality Rates and Trends—An Update. Cancer Epidemiology, Biomarkers & Prevention: A Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology, 25, 16.
https://doi.org/10.1158/1055-9965.EPI-15-0578
|
[5]
|
(2013) Breakthrough of the Year 2013. Notable Develop-ments. Science, 342, 1435.
|
[6]
|
Banasavadi-Siddegowda, Y.K., Russell, L., Frair, E., Karkhanis, V.A., et al. (2016) PRMT5-PTEN Molecular Pathway Regulates Senescence and Self-Renewal of Primary Glioblastoma Neurosphere Cells. Oncogene, 36.
|
[7]
|
Li, X., Li, L., Huang, Y., et al. (2017) Synergistic Therapy of Chemotherapeutic Drugs and MTH1 Inhibitors Using a pH-Sensitive Polymeric Delivery System for Oral Squamous Cell Carcinoma. Biomaterials Science, 5, 2068.
https://doi.org/10.1039/C7BM00395A
|
[8]
|
Helleday, T. (2015) Poisoning Cancer Cells with Oxidized Nucleosides. New England Journal of Medicine, 373, 1570-1571. https://doi.org/10.1056/NEJMcibr1510335
|
[9]
|
Wang, J.Y., Jin, L., Yan, X.G., et al. (2016) Reactive Oxygen Species Dictate the Apoptotic Response of Melanoma Cells to TH588. Journal of Investigative Dermatology, 136, 2277-2286. https://doi.org/10.1016/j.jid.2016.06.625
|
[10]
|
Sharma, P. and Allison, J.P. (2015) The Future of Immune Checkpoint Therapy. Science, 348, 56.
https://doi.org/10.1126/science.aaa8172
|
[11]
|
Helleday, T. (2014) Cancer Phenotypic Lethality, Exemplified by the Non-Essential MTH1 Enzyme Being Required for Cancer Survival. Annals of Oncology Official Journal of the European Society for Medical Oncology, 25, 1253-1255. https://doi.org/10.1093/annonc/mdu158
|
[12]
|
Smits, V.A. and Gil-lespie, D.A. (2014) Cancer Therapy. Cell Cycle, 13, 2330-2333. https://doi.org/10.4161/cc.29756
|
[13]
|
APANakabeppu, Y. (2014) Cellular Levels of 8-Oxoguanine in either DNA or the Nucleotide Pool Play Pivotal Roles in Carcinogenesis and Survival of Cancer Cells. International Journal of Mo-lecular Sciences, 15, 12543-12557.
https://doi.org/10.3390/ijms150712543
|
[14]
|
Nakabeppu, Y., Ohta, E. and Abolhassani, N. (2016) MTH1 as a Nu-cleotide Pool Sanitizing Enzyme: Friend or Foe? Free Radical Biology & Medicine, 107, 151-158.
|
[15]
|
Salman, K.A. and Ashraf, S. (2015) Reactive Oxygen Species: A Link between Chronic Inflammation and Cancer. Asia-Pacific Journal of Molecular Biology and Biotechnology, 22, 42-49.
|
[16]
|
Venza, M., Visalli, M., Beninati, C., et al. (2015) Cellular Mechanisms of Oxidative Stress and Action in Melanoma. Oxidative Medicine & Cellular Longevity, 2015, Article ID: 481782. https://doi.org/10.1155/2015/481782
|
[17]
|
Carter, M., Jemth, A.S., Hagenkort, A., et al. (2015) Crystal Structure, Biochemical and Cellular Activities Demonstrate Separate Functions of MTH1 and MTH2. Nature Communi-cations, 6, 7871.
https://doi.org/10.1038/ncomms8871
|
[18]
|
Dan, D. and He, C. (2014) Cancer: Damage Prevention Targeted. Nature, 508, 191-192.
https://doi.org/10.1038/nature13221
|
[19]
|
Huber, K.V., Salah, E., Radic, B., et al. (2014) Stereospecific Targeting of MTH1 by (S)-Crizotinib as an Anticancer Strategy. Nature, 508, 222-227. https://doi.org/10.1038/nature13194
|
[20]
|
Eshtad, S. (2017) Targeting DNA Repair Pathways for Cancer Therapy. PhD Thesis, Karolinska Institutet, Stockholm.
|
[21]
|
Abbas, H.H.K., Alhamoudi, K.M.H., Evans, M.D., et al. (2017) MTH1 Deficiency Selectively Increases Non-Cytotoxic Oxidative DNA Damage in Lung Cancer Cells: More Bad News than Good?
https://doi.org/10.1101/195750
|
[22]
|
Sohraby, F., Bagheri, M., Javaheri, M.M., et al. (2017) In Silico Prediction of New Inhibitors for the Nucleotide Pool Sanitizing Enzyme, MTH1, using Drug Repurposing. Journal of Biomolecular Structure & Dynamics.
https://doi.org/10.1080/07391102.2017.1365013
|
[23]
|
Samaranayake, G.J., Huynh, M. and Rai, P. (2017) MTH1 as a Chemotherapeutic Target: The Elephant in the Room. Cancers, 9, E47. https://doi.org/10.3390/cancers9050047
|
[24]
|
Akiyama, S., Saeki, H., Nakashima, Y., et al. (2017) Prognostic Im-pact of MutT Homolog-1 Expression on Esophageal Squamous Cell Carcinoma. Cancer Medicine, 6, 258-266. https://doi.org/10.1002/cam4.979
|
[25]
|
康从民, 王晓丽. 核酸氧化损伤修复酶MTH1及其抑制剂的研究进展[J]. 中国药理学通报, 2016, 32(8): 1044-1048.
|
[26]
|
Kettle, J.G., Alwan, H., Bista, M., et al. (2016) Potent and Selec-tive Inhibitors of MTH1 Probe Its Role in Cancer Cell Survival. Journal of Medicinal Chemistry, 59, 2346-2361. https://doi.org/10.1021/acs.jmedchem.5b01760
|
[27]
|
Tatsuro, K., Makoto, K., Makoto, M., et al. (2016) Proteomic Profiling of Small-Molecule Inhibitors Reveals Dispensability of MTH1 for Cancer Cell Survival. Scientific Reports, 6, Article No. 26521. https://doi.org/10.1038/srep26521
|
[28]
|
Ellermann, M., Eheim, A., Rahm, F., et al. (2017) Novel Class of Potent and Cellularly Active Inhibitors De-Validates MTH1 as Broad-Spectrum Cancer Target. ACS Chemical Biology, 12, 1986-1992.
https://doi.org/10.1021/acschembio.7b00370
|
[29]
|
Warpman, B.U., Sanjiv, K., Gad, H., et al. (2016) Validation and Development of MTH1 Inhibitors for Treatment of Cancer. Annals of Oncology Official Journal of the European Society for Medical Oncology, 27, 2275-2283.
https://doi.org/10.1093/annonc/mdw429
|